Skip to main content

Great take away points Marty. The interaction particularly between the analytical chemistry field and the medical sciences is crucial to improving diagnostic methods. However, I think that the complexity of these technologies, particularly the new advances in mass spectrometry that Dr. Gerszten described in his Grand Rounds talk, and the unfamiliarity that many health care practitioners may have with these technologies could present a barrier to widespread clinical implementation. If implemented in a clinic, not only would there need to be someone who is able to successfully perform the mass spec, but there would also need to be established guidelines for how to integrate the results of this test into the diagnostic process. I agree with your assessment that this technology has the potential for many fascinating improvements in medicine, but I'm curious what you think about these barriers to implementation. Thanks again for your post!

Name
Matthew James

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.